3 completed, 1 active not recruiting, 1 unknown, 1 withdrawn. 2 Not applicable, 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Sodium chloride (placebo): new trials by email Literature Review of Sodium chloride (placebo) trials Research Report on Sodium chloride (placebo)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET 18F-FDG (oral), 18F-FDG (intravenous), 18F-FET (oral) - Glucose Metabolism, NAFLD (Nonalcoholic Fatty Liver Disease) | Not applicable | Active not recruiting | Copenhagen University Hospital, Rigshospitalet | 36 | 2024-11-05 | 2026-02-02 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery PDNO, Sodium chloride (placebo) - Pulmonary Hypertension | Phase 2 | Unknown | Attgeno AB | 12 | 2022-10-23 | 2023-08-01 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension Sodium chloride (placebo), PDNO - Pulmonary Hypertension, COVID-19 | Phase 1 / Phase 2 | Withdrawn | Attgeno AB | 2021-05-07 | 2023-08-01 | |
| A First-in-Human Study to Assess the Safety and Tolerability of PDNO PDNO, Sodium chloride (placebo) - Pulmonary Hypertension | Phase 1 | Completed | Attgeno AB | 38 | 2021-02-02 | 2023-01-19 |
| Iron Status and Human Metabolism Ferric carboxymaltose, Sodium chloride (placebo) - Iron Deficiency | Not applicable | Completed | University of Oxford | 29 | 2014-10-01 | 2022-07-19 |
| Etanercept Treatment in the Early Course of Polymyalgia Rheumatica Etanercept (Enbrel), Sodium chloride (placebo) - Polymyalgia Rheumatica | Phase 3 | Completed | Bispebjerg Hospital | 40 | 2007-08-01 | 2010-02-23 |
Hypertension, Pulmonary (3) · COVID-19 (1) · Iron Deficiencies (1) · Non-alcoholic Fatty Liver Disease (1) · Polymyalgia Rheumatica (1)
Attgeno AB (3) · Bispebjerg Hospital (1) · Copenhagen University Hospital, Rigshospitalet (1) · University of Oxford (1)
Sweden (3) · Denmark (2) · United Kingdom (1)
Cecilia Kemi, PhD (2) · Henrik Galbo, Professor (1) · Matthew C Frise, MRCP (1) · Peter A Robbins, DPhil (1)